(Q38453666)

English

The potential of cytotherapeutics in hematologic reconstitution and in the treatment and prophylaxis of graft-versus-host disease. Chapter I: current practice and remaining unmet medical needs

scientific article published on January 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

1 reference

Europe PubMed Central

The potential of cytotherapeutics in hematologic reconstitution and in the treatment and prophylaxis of graft-versus-host disease. Chapter I: current practice and remaining unmet medical needs (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25933241%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

author name string

Alain A Vertès

1

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 2015

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Regenerative Medicine

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25933241%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25933241%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25933241%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

331-343

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25933241%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Allogeneic haematopoietic stem cell transplantation: individualized stem cell and immune therapy of cancer.

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Hematopoietic stem-cell transplantation

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

History of haematopoietic stem-cell transplantation.

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Hematopoietic-cell transplantation at 50.

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Emerging concepts in haematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Graft-versus-leukemia effects of transplantation and donor lymphocytes

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Novel strategies for the treatment and diagnosis of graft-versus-host-disease

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Current and emerging strategies for the prevention of graft-versus-host disease

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

History of hematopoietic stem cell transplantation: evolution and perspectives

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Dissecting graft-versus-leukemia from graft-versus-host-disease using novel strategies

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Concise review: acute graft-versus-host disease: immunobiology, prevention, and treatment

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Advances in the treatment of acute graft-versus-host disease.

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Effector CD4+ T cells, the cytokines they generate, and GVHD: something old and something new.

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Antigen CD34+ marrow cells engraft lethally irradiated baboons

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Many mechanisms mediating mobilization: an alliterative review

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Plerixafor on-demand combined with chemotherapy and granulocyte colony-stimulating factor: significant improvement in peripheral blood stem cells mobilization and harvest with no increase in costs.

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Plerixafor plus granulocyte CSF can mobilize hematopoietic stem cells from multiple myeloma and lymphoma patients failing previous mobilization attempts: EU compassionate use data

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies.

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

History of cord blood transplantation

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Cord blood stem cells for hematopoietic stem cell transplantation in the UK: how big should the bank be?

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Cord blood CD4(+)CD25(+)-derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Current status of umbilical cord blood hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Assessment of optimal size and composition of the U.S. National Registry of hematopoietic stem cell donors.

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Optimizing unrelated donor cord blood transplantation

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Umbilical cord blood transplantation: the first 25 years and beyond

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

New strategies for haploidentical transplantation

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Unmanipulated haploidentical bone marrow transplantation and posttransplantation cyclophosphamide for hematologic malignancies after myeloablative conditioning.

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

One million haemopoietic stem-cell transplants: a retrospective observational study

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Hematopoietic stem cell transplantation: a global perspective

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Hematopoietic stem cell transplantation activity in Europe.

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Acute GvHD: pathogenesis and classification

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Prophylaxis regimens for GVHD: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Prevention and treatment of acute GvHD.

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Acute graft-versus-host disease in children

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Optimal management of chronic graft-versus-host disease in children

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Pathophysiology of graft-versus-host disease

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Genetically engineered donor T cells to optimize graft-versus-tumor effects across MHC barriers

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Anti-thymocyte globulins for post-transplant graft-versus-host disease prophylaxis-A systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Antilymphocyte/thymocyte globulin for graft versus host disease prophylaxis: efficacy and side effects

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT.

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Graft-versus-host disease in dog and man: the Seattle experience

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

What predicts high risk acute graft-versus-host disease (GVHD) at onset?: identification of those at highest risk by a novel acute GVHD risk score

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Steroid-Refractory Acute GVHD: Predictors and Outcomes.

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Shared biology of GVHD and GVT effects: potential methods of separation

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Separation of graft-vs.-tumor effects from graft-vs.-host disease in allogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Graft-versus-host disease

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Duration of immunosuppressive treatment for chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Extracorporeal photopheresis versus anticytokine therapy as a second-line treatment for steroid-refractory acute GVHD: a multicenter comparative analysis.

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Attributable hospital cost and antifungal treatment of invasive fungal diseases in high-risk hematology patients: an economic modeling approach

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Economics of hematopoietic cell transplantation.

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Hematopoietic cell transplantation: progress and obstacles

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Novel drugs for the prevention and treatment of acute GVHD.

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Current and novel therapies in acute GVHD.

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Plasma biomarkers of lower gastrointestinal and liver acute GVHD.

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

The best endpoint for acute GVHD treatment trials

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Treatment costs and survival in patients with grades III-IV acute graft-versus-host disease after allogenic hematopoietic stem cell transplantation during three decades

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Progress and prospects for engineered T cell therapies

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Mesenchymal stromal cells: sensors and switchers of inflammation

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Mesenchymal stem cells: mechanisms of inflammation

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Cord Blood Transplantation: Can We Make it Better?

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Bone marrow mesenchymal stromal cells to treat complications following allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Mesenchymal stem cell therapy and acute graft-versus-host disease: a review

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

The potential of cytotherapeutics in hematologic reconstitution and in the treatment and prophylaxis of graft-versus-host disease. Chapter II: emerging transformational cytotherapies.

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Hematopoietic SCT activity in Asia: a report from the Asia-Pacific Blood and Marrow Transplantation Group

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Steroid-Refractory Acute GVHD: Lack of Long-Term Improved Survival Using New Generation Anticytokine Treatment

1 reference

https://api.crossref.org/works/10.2217%2FRME.15.12

21 January 2018

Identifiers

10.2217/RME.15.12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25933241%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25933241%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38453666&oldid=1760407661"